Insight Enterprises diskutieren
Insight Enterprises
WKN: 909619 / Symbol: NSIT / Name: Insight Enterp / Aktie / Software & Informationsdienstleistungen / Small Cap /
69,20 €
-2,04 %
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $168.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its price target raised by analysts at Barrington Research from $168.00 to $184.00. They now have an "outperform" rating on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its price target raised by analysts at Barrington Research from $184.00 to $211.00. They now have an "outperform" rating on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $211.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $211.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its price target raised by analysts at Barrington Research from $211.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $225.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $225.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its price target lowered by analysts at Barrington Research from $225.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $220.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its price target lowered by analysts at Barrington Research from $205.00 to $164.00. They now have an "outperform" rating on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $164.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises, Inc. (NASDAQ: NSIT) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $164.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises (NASDAQ:NSIT) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $164.00 price target on the stock.
Ratings data for NSIT provided by MarketBeat
Insight Enterprises (NASDAQ:NSIT) had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $90.00 price target on the stock, down previously from $117.00.
Ratings data for NSIT provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Biocryst Pharmaceuticals diskutieren